Shenzhen Bioeasy Biotechnology Co., Ltd. (300942.SZ)
CNY 8.82
(2.92%)
CNY 8.82
(2.92%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 254.1 Million CNY | -63.01% |
| 2022 | 686.89 Million CNY | 14.95% |
| 2021 | 597.53 Million CNY | 131.2% |
| 2020 | 258.45 Million CNY | 8.06% |
| 2019 | 239.17 Million CNY | 16.71% |
| 2018 | 204.93 Million CNY | 48.62% |
| 2017 | 137.88 Million CNY | 58.41% |
| 2016 | 87.04 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 36.37 Million CNY | -59.13% |
| 2024 Q2 | 66.99 Million CNY | 84.18% |
| 2023 Q1 | 60.7 Million CNY | -47.12% |
| 2023 Q3 | 52.98 Million CNY | 3.08% |
| 2023 Q2 | 51.4 Million CNY | -15.33% |
| 2023 FY | 254.1 Million CNY | -63.01% |
| 2023 Q4 | 89 Million CNY | 67.98% |
| 2022 Q2 | 180.66 Million CNY | -38.55% |
| 2022 Q4 | 114.8 Million CNY | 17.84% |
| 2022 Q1 | 294 Million CNY | 76.61% |
| 2022 Q3 | 97.42 Million CNY | -46.07% |
| 2022 FY | 686.89 Million CNY | 14.95% |
| 2021 Q1 | 146.91 Million CNY | 104.16% |
| 2021 Q2 | 183.57 Million CNY | 24.95% |
| 2021 Q3 | 100.58 Million CNY | -45.21% |
| 2021 Q4 | 166.46 Million CNY | 65.5% |
| 2021 FY | 597.53 Million CNY | 131.2% |
| 2020 Q3 | 54.9 Million CNY | -7.53% |
| 2020 Q1 | 72.2 Million CNY | -24.21% |
| 2020 FY | 258.45 Million CNY | 8.06% |
| 2020 Q4 | 71.96 Million CNY | 31.06% |
| 2020 Q2 | 59.37 Million CNY | -17.77% |
| 2019 Q4 | 95.27 Million CNY | 0.0% |
| 2019 FY | 239.17 Million CNY | 16.71% |
| 2019 Q1 | 42.85 Million CNY | 0.0% |
| 2018 FY | 204.93 Million CNY | 48.62% |
| 2017 FY | 137.88 Million CNY | 58.41% |
| 2016 FY | 87.04 Million CNY | 0.0% |